Dogwood Therapeutics Inc.
DWTX | NASDAQ
$1.65
+$0.05 (+3.12%)
Sep 22, 2026, 12:56 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 16.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -16.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -29.56M | -28.61M | -27.97M | -31.7M | -18.2M | -15.34M | -12.23M | -5.82M | -4.8M | -5.2M | -5.45M | -6.4M | -7.72M | -9.91M | -12.32M | -14.41M | -15.93M | -16.54M | -15.64M | -17.88M | -16.43M | -12.68M |
Interest Income | 276.35K | 321.38K | 244.03K | 191.96K | 131.87K | 40.48K | 63.25K | 98.2K | 116.93K | 133.25K | 150.9K | 161.11K | 138.5K | 106.99K | 67.48K | 23.58K | 8.49K | 5.18K | 5.67K | 4.4K | 2.9K | 1.4K |
Pretax Income | -38.49M | -28.29M | -34.04M | -38.02M | -24.55M | -21.79M | -12.35M | -5.73M | -4.68M | -5.07M | -5.3M | -6.24M | -7.58M | -9.8M | -12.25M | -14.71M | -16.25M | -16.86M | -15.96M | -17.95M | -16.56M | -12.94M |
Net Income | -36.04M | -28.32M | -34.26M | -38.2M | -24.74M | -21.98M | -12.35M | -5.73M | -4.68M | -5.07M | -5.3M | -6.24M | -7.58M | -9.8M | -12.25M | -14.71M | -16.25M | -16.86M | -15.96M | -17.95M | -16.56M | -12.94M |
Selling & General & Admin | 6.77M | 6.52M | 6.1M | 9.86M | 10.34M | 9.72M | 8.7M | 4.31M | 3.44M | 3.63M | 3.72M | 3.7M | 3.77M | 4.11M | 4.25M | 4.7M | 4.88M | 4.69M | 4.85M | 9.97M | 11.37M | 10.81M |
Research & Development | 22.78M | 22.1M | 21.87M | 21.84M | 7.86M | 5.62M | 3.53M | 1.51M | 1.35M | 1.57M | 1.73M | 2.7M | 3.95M | 5.8M | 8.07M | 9.72M | 11.06M | 11.86M | 10.8M | 7.91M | 5.06M | 1.87M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.55M | 28.61M | 27.97M | 31.7M | 18.2M | 15.34M | 12.23M | 5.82M | 4.8M | 5.2M | 5.45M | 6.4M | 7.72M | 9.91M | 12.32M | 14.41M | 15.93M | 16.54M | 15.64M | 17.88M | 16.43M | 12.68M |
Interest Expense | n/a | n/a | 147.09K | 302.53K | 302.53K | 302.53K | 155.44K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 79.58K | 184.02K | 300.22K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 29.56M | 28.61M | 27.97M | 31.7M | 18.2M | 15.34M | 12.23M | 5.82M | 4.8M | 5.2M | 5.45M | 6.4M | 7.72M | 9.91M | 12.32M | 14.41M | 15.93M | 16.54M | 15.64M | 17.88M | 16.43M | 12.68M |
Income Tax Expense | -2.45M | 29.36K | 221.1K | 188.75K | 190.19K | 190.04K | -503 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 34.13M | 33.54M | 14.52M | 1.92M | 1.44M | 1.44M | 1.31M | 1.11M | 916.03K | 770.32K | 770.32K | 763.75K | 736.46K | 733.22K | 733.22K | 368K | 333.22K | 333.22K | 333.22K | 333.22K | 333.22K | 333.04K |
Shares Outstanding (Diluted) | 34.13M | 33.54M | 14.52M | 1.92M | 1.44M | 1.44M | 1.31M | 1.11M | 916.03K | 770.32K | 770.32K | 763.75K | 736.46K | 733.22K | 733.22K | 368K | 333.22K | 333.22K | 333.22K | 333.22K | 333.22K | 333.04K |
EPS (Basic) | -8.95 | -10.60 | -18.90 | -24.54 | -18.39 | -17.55 | -10.78 | -6.31 | -5.88 | -6.69 | -7.08 | -8.44 | -13.82 | -22.87 | -32.69 | -43.44 | -48.77 | -50.61 | -47.90 | -65.54 | -67.17 | -57.71 |
EPS (Diluted) | -8.95 | -10.60 | -18.90 | -24.54 | -18.39 | -17.55 | -10.78 | -6.31 | -5.88 | -6.69 | -7.08 | -8.44 | -13.82 | -22.87 | -32.69 | -43.44 | -48.77 | -50.61 | -47.90 | -65.54 | -67.17 | -57.71 |
EBITDA | -29.3M | -28.24M | -33.84M | -37.66M | -24.21M | -21.47M | -12.19M | -5.73M | -4.68M | -5.07M | -5.3M | -6.24M | -7.58M | -9.8M | -12.25M | -14.71M | -16.25M | -16.86M | -15.96M | -17.87M | -16.42M | -12.68M |
EBIT | -29.35M | -28.29M | -33.89M | -37.71M | -24.25M | -21.49M | -12.19M | -5.73M | -4.68M | -5.07M | -5.3M | -6.24M | -7.58M | -9.8M | -12.25M | -14.71M | -16.25M | -16.86M | -15.96M | -17.87M | -16.42M | -12.68M |
Depreciation & Amortization | 50.78K | 51.35K | 51.53K | 51.53K | 34.28K | 17.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DWTX